Recent Advances in the Potential Use of Circular RNA for the Diagnosis and Treatment of Pancreatic Cancer
- PMID: 34093039
- PMCID: PMC8168960
- DOI: 10.2147/CMAR.S308809
Recent Advances in the Potential Use of Circular RNA for the Diagnosis and Treatment of Pancreatic Cancer
Abstract
There are few biomarkers available for the early diagnosis and prognostic evaluation of pancreatic cancer. In addition, the development of targeted therapy for pancreatic cancer is an unmet need due to the lack of molecular targets. With the continuous progress in circular RNA (circRNA)-related research, its role in the occurrence and development of pancreatic cancer has been discovered and gradually recognized. Therefore, circRNA may represent a novel marker for early diagnosis of this disease and a focus of targeted clinical therapy. CircRNA is a type of non-coding RNA with a closed circular structure formed by covalent bonds. Some circRNAs can act as "sponges" to adsorb microRNAs (miRNAs) and play the role of competitive endogenous RNA (ceRNA) to remove their inhibitory effects on the target genes of miRNA. Thus, they can indirectly restore the expression of target genes. The circRNA-miRNA-mRNA network plays a regulatory role in the proliferation, invasion, metastasis, and other biological behaviors of pancreatic cancer. Given the recent advances in circRNA, this review seeks to provide an overview of the biological function of circRNA and highlights the recent research progress regarding the molecular mechanism of circRNA for the clinical diagnosis and treatment of pancreatic cancer.
Keywords: biological function; biomarker; circular RNA; pancreatic cancer; targeted therapy.
© 2021 Sun et al.
Conflict of interest statement
Dr Nan Ge reports grants from Natural Science Foundation of Liaoning Province (Grant No. 20180530014), during the conduct of the study; Dr Jintao Guo report grants from National Natural Science Foundation of China (Grant No. 81900601), during the conduct of the study. Dr Siyu Sun reports grants from University innovation team and innovative talent support program of Liaoning Province (Grant No. LR2019073), from Outstanding Scientific Fund of Shengjing Hospital (Grant No. 201701), during the conduct of the study. The authors report no conflicts of interest in this work.
Similar articles
-
Whole-transcriptome analysis reveals a potential hsa_circ_0001955/hsa_circ_0000977-mediated miRNA-mRNA regulatory sub-network in colorectal cancer.Aging (Albany NY). 2020 Mar 28;12(6):5259-5279. doi: 10.18632/aging.102945. Epub 2020 Mar 28. Aging (Albany NY). 2020. PMID: 32221048 Free PMC article.
-
Identification of circRNA-lncRNA-miRNA-mRNA Competitive Endogenous RNA Network as Novel Prognostic Markers for Acute Myeloid Leukemia.Genes (Basel). 2020 Jul 31;11(8):868. doi: 10.3390/genes11080868. Genes (Basel). 2020. PMID: 32751923 Free PMC article.
-
Role of circular RNAs in gastric cancer: Recent advances and prospects.World J Gastrointest Oncol. 2019 Jun 15;11(6):459-469. doi: 10.4251/wjgo.v11.i6.459. World J Gastrointest Oncol. 2019. PMID: 31236197 Free PMC article. Review.
-
Crosstalk in competing endogenous RNA networks reveals new circular RNAs involved in the pathogenesis of early HIV infection.J Transl Med. 2018 Nov 29;16(1):332. doi: 10.1186/s12967-018-1706-1. J Transl Med. 2018. PMID: 30486834 Free PMC article.
-
Epigenetic Associations between lncRNA/circRNA and miRNA in Hepatocellular Carcinoma.Cancers (Basel). 2020 Sep 14;12(9):2622. doi: 10.3390/cancers12092622. Cancers (Basel). 2020. PMID: 32937886 Free PMC article. Review.
Cited by
-
Dysregulation of the circ_0087502/miR-1179/TGFBR2 pathway supports gemcitabine resistance in pancreatic cancer.Cancer Biol Ther. 2023 Dec 31;24(1):2258566. doi: 10.1080/15384047.2023.2258566. Epub 2023 Oct 16. Cancer Biol Ther. 2023. PMID: 37844011 Free PMC article.
-
CircRNAs in Pancreatic Cancer: New Tools for Target Identification and Therapeutic Intervention.Cancer Genomics Proteomics. 2024 Jul-Aug;21(4):327-349. doi: 10.21873/cgp.20451. Cancer Genomics Proteomics. 2024. PMID: 38944427 Free PMC article. Review.
-
CircATP13A1 (hsa_circ_0000919) promotes cell proliferation and metastasis and inhibits cell apoptosis in pancreatic ductal adenocarcinoma via the miR-186/miR-326/HMGA2 axis: implications for novel therapeutic targets.Am J Cancer Res. 2023 Nov 15;13(11):5610-5625. eCollection 2023. Am J Cancer Res. 2023. PMID: 38058810 Free PMC article.
-
Hsa_circ_0128846 knockdown attenuates the progression of pancreatic cancer by targeting miR-1270/NR3C1 axis.Sci Rep. 2023 Feb 16;13(1):2792. doi: 10.1038/s41598-023-28439-w. Sci Rep. 2023. PMID: 36797317 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources